Key result
Clinical management of stable ischemic heart disease involves noninvasive imaging, medical optimization of comorbidities, and individualized revascularization for persistent symptoms.
Provides an overview of the clinical management of stable ischemic heart disease, including diagnostic imaging, medical therapy optimization, and indications for revascularization.
May support comorbidity optimization in stable CAD; leaves open validation in prospective cohorts.
Ischemic heart disease is considered stable, if patients are asymptomatic or have well controlled symptoms. Based on the pretest probability, noninvasive imaging tests are performed to rule out the disease, and coronary computed tomography angiography being the first line. Invasive coronary angiography remains the gold standard method for diagnosing coronary artery disease. In patients with stable coronary artery disease, comorbidities such as hyperlipidemia, hypertension, and diabetes should be optimized. For patients with persistent anginal symptoms even with optimized medical therapy, coronary revascularization with percutaneous coronary intervention can be considered. Coronary artery bypass grafting may be more beneficial for patients who has stable coronary artery disease with left main disease and/or left ventricular dysfunction and/or multivessel disease; however, treatment should be individualized to the overall clinical picture.
No takes yet. Share an insight, caveat, or question.
Dey et al. (2023) conducted a review in Stable Ischemic Heart Disease. Clinical management of stable ischemic heart disease involves noninvasive imaging, medical optimization of comorbidities, and individualized revascularization for persistent symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: